Leonhard Muellauer

557 total citations
21 papers, 263 citations indexed

About

Leonhard Muellauer is a scholar working on Genetics, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Leonhard Muellauer has authored 21 papers receiving a total of 263 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 7 papers in Pathology and Forensic Medicine and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Leonhard Muellauer's work include Lymphoma Diagnosis and Treatment (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Leonhard Muellauer is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Leonhard Muellauer collaborates with scholars based in Austria, Germany and United Kingdom. Leonhard Muellauer's co-authors include Markus Raderer, Andreas Chott, Berthold Streubel, Franz Trautinger, Constanze Jonak, Julia Valencak, Peter Valent, Barbara Kiesewetter, Andrew Wotherspoon and Werner Dolak and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

Leonhard Muellauer

20 papers receiving 258 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leonhard Muellauer Austria 8 127 66 65 57 52 21 263
Julie C. Porcher United States 8 213 1.7× 69 1.0× 126 1.9× 106 1.9× 100 1.9× 13 399
Ana Dotor Spain 7 162 1.3× 70 1.1× 175 2.7× 85 1.5× 90 1.7× 12 404
K. Boye France 7 148 1.2× 81 1.2× 154 2.4× 61 1.1× 60 1.2× 8 316
Zifen Gao China 11 194 1.5× 41 0.6× 158 2.4× 46 0.8× 23 0.4× 22 280
Akito Dobashi Japan 9 205 1.6× 69 1.0× 188 2.9× 83 1.5× 69 1.3× 18 384
Lauris Gastaud France 12 110 0.9× 65 1.0× 191 2.9× 64 1.1× 21 0.4× 36 395
Noraidah Masir Malaysia 12 205 1.6× 77 1.2× 163 2.5× 90 1.6× 22 0.4× 48 396
Eisuke Shiozawa Japan 12 189 1.5× 47 0.7× 182 2.8× 75 1.3× 20 0.4× 39 366
Kristina Hinz Germany 7 216 1.7× 60 0.9× 107 1.6× 59 1.0× 19 0.4× 16 304
Shereen Gheith United States 7 63 0.5× 147 2.2× 61 0.9× 72 1.3× 37 0.7× 17 284

Countries citing papers authored by Leonhard Muellauer

Since Specialization
Citations

This map shows the geographic impact of Leonhard Muellauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonhard Muellauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonhard Muellauer more than expected).

Fields of papers citing papers by Leonhard Muellauer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leonhard Muellauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonhard Muellauer. The network helps show where Leonhard Muellauer may publish in the future.

Co-authorship network of co-authors of Leonhard Muellauer

This figure shows the co-authorship network connecting the top 25 collaborators of Leonhard Muellauer. A scholar is included among the top collaborators of Leonhard Muellauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leonhard Muellauer. Leonhard Muellauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hofstetter, Gerda, et al.. (2024). Prognostic role of transcription factor ARID1A in patients with endometrial cancer of no specific molecular profile (NSMP) subtype. International Journal of Gynecological Cancer. 34(6). 840–846. 7 indexed citations
2.
Grimm, Christoph, Núria Seguí, Christian Brueffer, et al.. (2024). Tumor-informed ctDNA as an objective marker for postoperative residual disease in epithelial ovarian cancer.. Journal of Clinical Oncology. 42(16_suppl). 5544–5544. 1 indexed citations
3.
Wolf, Andrea, et al.. (2023). Biomarkers for checkpoint inhibitor therapy in mucinous epithelial ovarian cancer. International Journal of Gynecological Cancer. 33(9). 1419–1426. 2 indexed citations
4.
Mair, Maximilian J., Barbara Kiesel, Georg Widhalm, et al.. (2020). Lymphocyte-activation gene 3 (LAG-3) expression in the inflammatory microenvironment of glioma.. Journal of Clinical Oncology. 38(15_suppl). 2553–2553. 6 indexed citations
5.
Starzer, Angelika M., Gerwin Heller, Erwin Tomasich, et al.. (2020). DNA methylation profiling in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors.. Journal of Clinical Oncology. 38(15_suppl). e18527–e18527.
6.
Greiner, Georg, Franz Ratzinger, Nadine Witzeneder, et al.. (2017). Digital Droplet PCR: Next Generation KIT D816V Testing As Advanced Tool for Diagnosis and Prognostication in Mastocytosis. Blood. 130. 2927–2927. 1 indexed citations
7.
Jeryczynski, Georg, Bettina Gisslinger, Martin Schalling, et al.. (2016). Prefibrotic Primary Myelofibrosis As an Entity Distinct from Other Philadelphia-Chromosome Negative Myeloproliferative Neoplasms - Data from the Austrian Reclassification Project. Blood. 128(22). 4252–4252. 1 indexed citations
8.
Takizawa, Jun, Michaela Gruber, Ritsuro Suzuki, et al.. (2016). Comparative Analysis of Japanese and European Typical CLL Patients. Blood. 128(22). 5564–5564. 2 indexed citations
9.
Raderer, Markus, Stefan Wöhrer, Barbara Kiesewetter, et al.. (2015). Antibiotic treatment as sole management of Helicobacter pylori-negative gastric MALT lymphoma: a single center experience with prolonged follow-up. Annals of Hematology. 94(6). 969–973. 38 indexed citations
10.
Gisslinger, Heinz, Jüergen Thiele, Bettina Gisslinger, et al.. (2014). Calreticulin Mutation Status Predicts Improved Disease Outcome in Prefibrotic Primary Myelofibrosis but Not in WHO-Defined Essential Thrombocythemia. Blood. 124(21). 3167–3167. 1 indexed citations
11.
Barbui, Tiziano, Jürgen Thiele, Heinz Gisslinger, et al.. (2013). Masked Polycythemia Vera (mPV): Results Of An International Study. Blood. 122(21). 1581–1581. 1 indexed citations
12.
Buxhofer‐Ausch, Veronika, Martin Schalling, Sophie Frantal, et al.. (2013). Correlation Of Longitudinal Blood Counts With Thromboembolic Complications In WHO 2008 Defined Prefibrotic Primary Myelofibrosis. Blood. 122(21). 2834–2834. 1 indexed citations
13.
Cerny‐Reiterer, Sabine, Gregor Hoermann, Karl J. Aichberger, et al.. (2012). Identification of Basophils as a Major Source of Hepatocyte Growth Factor in Chronic Myeloid Leukemia: A Novel Mechanism of BCR-ABL1-Independent Disease Progression. Neoplasia. 14(7). 572–IN10. 44 indexed citations
14.
Dolak, Werner, Markus Raderer, Judith Maresch, et al.. (2011). Detection of gastric MALT lymphoma spreading to the small bowel by enteroscopy. Endoscopy. 43(8). 731–733. 4 indexed citations
15.
Valencak, Julia, Katharina Schmid, Franz Trautinger, et al.. (2011). High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas. Journal of Dermatological Science. 64(3). 185–190. 24 indexed citations
16.
Hoffmann, Martha, Marlene Troch, Harald Eidherr, et al.. (2010). 90Y-ibritumomab tiuxetan (Zevalin) in heavily pretreated patients with mucosa associated lymphoid tissue lymphoma. Leukemia & lymphoma. 52(1). 42–45. 16 indexed citations
17.
Gruenberger, Birgit, Marlene Troch, W. Hauff, et al.. (2008). Assessment of the role of hepatitis C,Helicobacter pyloriand autoimmunity in MALT lymphoma of the ocular adnexa in 45 Austrian patients. Acta Oncologica. 47(3). 355–359. 22 indexed citations
18.
Valencak, Julia, Felix Weihsengruber, Klemens Rappersberger, et al.. (2008). Rituximab monotherapy for primary cutaneous B-cell lymphoma: response and follow-up in 16 patients. Annals of Oncology. 20(2). 326–330. 45 indexed citations
19.
Wolfesberger, Birgitt, Wilhelm Gerner, Ingrid Miller, et al.. (2007). Expression of Vascular Endothelial Growth Factor and its Receptors in Canine Lymphoma. Journal of Comparative Pathology. 137(1). 30–40. 27 indexed citations
20.
Krauth, Maria Theresa, Hermine Agis, Karl J. Aichberger, et al.. (2004). Histidine Decarboxylase (HDC) as Novel Marker of Immature Neoplastic Mast Cells in Systemic Mastocytosis.. Blood. 104(11). 4755–4755. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julie C. Porcher Breakdown of academic impact, for papers by Ana Dotor Breakdown of academic impact, for papers by K. Boye Breakdown of academic impact, for papers by Zifen Gao Breakdown of academic impact, for papers by Akito Dobashi Breakdown of academic impact, for papers by Lauris Gastaud Breakdown of academic impact, for papers by Noraidah Masir Breakdown of academic impact, for papers by Eisuke Shiozawa Breakdown of academic impact, for papers by Kristina Hinz Breakdown of academic impact, for papers by Shereen Gheith
Rankless by CCL
2026